Population Pharmacokinetics of Atogepant for the Prevention of Migraine

Authors

Institutions

Publication Details

Journal
Clinical Pharmacokinetics
Published
2025-11-12
DOI
https://doi.org/10.1007/s40262-025-01566-5
Citations
2
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
2.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Population Pharmacokinetics of Atogepant for the Prevention of Migraine

Fredrik Jönsson, Louisa Schlachter, Ramesh Boinpally, Sven Stodtmann et al.
2 citations
Clinical Pharmacokinetics
Migraine and Headache Studies
2.94
article

Population Pharmacokinetics of Atogepant for the Prevention of Migraine

Fredrik Jönsson, Louisa Schlachter, Ramesh Boinpally, Sven Stodtmann, Alexander Voelkner, H. Maxime Lagraauw
article en
2 citations

Abstract

No abstract available for this paper.
Clinical PharmacokineticsVol. 65(1)
AbbVie (United States) (US), AbbVie (Germany) (DE)
Openalex Percentile: Top 8%
Migraine and Headache Studies
2.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.